The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

<div>Forest plot of the outcome of waist circumference reduction effect in overweight/obese PCOS patients. EXE: exenatide; LIRA: liraglutide; MET: metformin; COMBI: combination, represented GLP-1RAs combined with MET treatment; WMD: weighted mean difference.</div>

International Journal of Endocrinology

fig3

Figure 3

Figure 3: The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis 

Figure 3 | The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis 